BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23165953)

  • 1. Increased risk of breast cancer in women with NF1.
    Madanikia SA; Bergner A; Ye X; Blakeley JO
    Am J Med Genet A; 2012 Dec; 158A(12):3056-60. PubMed ID: 23165953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer and other neoplasms in women with neurofibromatosis type 1: a retrospective review of cases in the Detroit metropolitan area.
    Wang X; Levin AM; Smolinski SE; Vigneau FD; Levin NK; Tainsky MA
    Am J Med Genet A; 2012 Dec; 158A(12):3061-4. PubMed ID: 22965642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study.
    Evans DGR; Kallionpää RA; Clementi M; Trevisson E; Mautner VF; Howell SJ; Lewis L; Zehou O; Peltonen S; Brunello A; Harkness EF; Wolkenstein P; Peltonen J
    Genet Med; 2020 Feb; 22(2):398-406. PubMed ID: 31495828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast density in NF1 women: a retrospective study.
    De Santis R; Cagnoli G; Rinaldi B; Consonni D; Conti B; Eoli M; Liguori A; Cosentino M; Carrafiello G; Garrone O; Giroda M; Cesaretti C; Sfondrini MS; Gambini D; Natacci F
    Fam Cancer; 2024 Mar; 23(1):35-40. PubMed ID: 38270845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased breast cancer risk in women with neurofibromatosis type 1: a meta-analysis and systematic review of the literature.
    Suarez-Kelly LP; Yu L; Kline D; Schneider EB; Agnese DM; Carson WE
    Hered Cancer Clin Pract; 2019; 17():12. PubMed ID: 30962859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neurofibromin 1 type I isoform predominance characterises female population affected by sporadic breast cancer: preliminary data.
    Marrero D; Peralta R; Valdivia A; De la Mora A; Romero P; Parra M; Mendoza N; Mendoza M; Rodriguez D; Camacho E; Duarte A; Castelazo G; Vanegas E; Garcia I; Vargas C; Arenas D; Jimenez F; Salcedo M
    J Clin Pathol; 2012 May; 65(5):419-23. PubMed ID: 22412049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of second primary breast cancer among cancer survivors: Implications for prevention and screening practice.
    Cheng Y; Huang Z; Liao Q; Yu X; Jiang H; He Y; Yao S; Nie S; Liu L
    PLoS One; 2020; 15(6):e0232800. PubMed ID: 32497148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening.
    Sharif S; Moran A; Huson SM; Iddenden R; Shenton A; Howard E; Evans DG
    J Med Genet; 2007 Aug; 44(8):481-4. PubMed ID: 17369502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in breast cancer by race and ethnicity: update 2006.
    Smigal C; Jemal A; Ward E; Cokkinides V; Smith R; Howe HL; Thun M
    CA Cancer J Clin; 2006; 56(3):168-83. PubMed ID: 16737949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline and Somatic
    Wang X; Kallionpää RA; Gonzales PR; Chitale DA; Tousignant RN; Crowley JP; Chen Z; Yoder SJ; Blakeley JO; Acosta MT; Korf BR; Messiaen LM; Tainsky MA
    Cancer Prev Res (Phila); 2018 Oct; 11(10):655-664. PubMed ID: 30104415
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.
    Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA
    J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
    Kauff ND; Mitra N; Robson ME; Hurley KE; Chuai S; Goldfrank D; Wadsworth E; Lee J; Cigler T; Borgen PI; Norton L; Barakat RR; Offit K
    J Natl Cancer Inst; 2005 Sep; 97(18):1382-4. PubMed ID: 16174860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Second Primary Female Genital Malignancies in Women with Breast Cancer: a SEER Analysis.
    Li Z; Wu Q; Song J; Zhang Y; Zhu S; Sun S
    Horm Cancer; 2018 Jun; 9(3):197-204. PubMed ID: 29556910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Breast, Prostate, and Colorectal Cancer Diagnoses Among HIV-Infected Individuals in the United States.
    Coghill AE; Engels EA; Schymura MJ; Mahale P; Shiels MS
    J Natl Cancer Inst; 2018 Sep; 110(9):959-966. PubMed ID: 29529223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of lymphoma in women with breast implants: analysis of clinical studies.
    Largent J; Oefelein M; Kaplan HM; Okerson T; Boyle P
    Eur J Cancer Prev; 2012 May; 21(3):274-80. PubMed ID: 22456426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-exome sequencing of breast cancer, malignant peripheral nerve sheath tumor and neurofibroma from a patient with neurofibromatosis type 1.
    McPherson JR; Ong CK; Ng CC; Rajasegaran V; Heng HL; Yu WS; Tan BK; Madhukumar P; Teo MC; Ngeow J; Thike AA; Rozen SG; Tan PH; Lee AS; Teh BT; Yap YS
    Cancer Med; 2015 Dec; 4(12):1871-8. PubMed ID: 26432421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors.
    Uusitalo E; Kallionpää RA; Kurki S; Rantanen M; Pitkäniemi J; Kronqvist P; Härkönen P; Huovinen R; Carpen O; Pöyhönen M; Peltonen S; Peltonen J
    Br J Cancer; 2017 Jan; 116(2):211-217. PubMed ID: 27931045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased breast cancer rates among women with choriocarcinoma.
    Gudipudi DK; Hartzfeld K; Montemarano N; Del Priore G
    Gynecol Oncol; 2008 Aug; 110(2):202-5. PubMed ID: 18514799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer risk in neurofibromatosis type 1 is a function of the type of
    Frayling IM; Mautner VF; van Minkelen R; Kallionpaa RA; Aktaş S; Baralle D; Ben-Shachar S; Callaway A; Cox H; Eccles DM; Ferkal S; LaDuca H; Lázaro C; Rogers MT; Stuenkel AJ; Summerour P; Varan A; Yap YS; Zehou O; Peltonen J; Evans DG; Wolkenstein P; Upadhyaya M
    J Med Genet; 2019 Apr; 56(4):209-219. PubMed ID: 30530636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF1 Patients Receiving Breast Cancer Screening: Insights from The Ontario High Risk Breast Screening Program.
    Maani N; Westergard S; Yang J; Scaranelo AM; Telesca S; Thain E; Schachter NF; McCuaig JM; Kim RH
    Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31121919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.